E2F3 accelerates the stemness of colon cancer cells by activating the STAT3 pathway
IntroductionColon cancer is one of the most prevalent malignancies and causes of cancer-related deaths worldwide. Thus, further research is required to explicate the latent molecular mechanisms and look for novel biomarkers. E2F3 has been confirmed to be an oncogene in a variety of cancers. However,...
Main Authors: | Qingkun Gao, Ke An, Zhe Lv, Yanzhao Wang, Changmin Ding, Wensheng Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1203712/full |
Similar Items
-
Cirsiliol regulates mitophagy in colon cancer cells via STAT3 signaling
by: Tao Jiang, et al.
Published: (2022-10-01) -
STAT3 pathway in cancers: Past, present, and future
by: Han‐Qi Wang, et al.
Published: (2022-06-01) -
Treatment of Colon Cancer by Degradable rrPPC Nano-Conjugates Delivered STAT3 siRNA
by: Zhang H, et al.
Published: (2020-12-01) -
STAT3 activation in monocytes accelerates liver cancer progression
by: Wu Wen-Yong, et al.
Published: (2011-12-01) -
Secretory RAB GTPase 3C modulates IL6-STAT3 pathway to promote colon cancer metastasis and is associated with poor prognosis
by: Yu-Chan Chang, et al.
Published: (2017-08-01)